Isocolan

Sodium Hydrogen Carbonate, the active ingredient in Isocolan, is an electrolyte replenishment agent presented as an oral solution for oral use. It is combined with potassium chloride, sodium chloride, sodium sulfate anhydrous and macrogol 4 to help restore fluid and electrolyte balance in patients who have experienced fluid loss. GNH USA supplies Isocolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isocolan is used primarily to address conditions that involve fluid and electrolyte disturbances. - Dehydration: helps re‑hydrate patients by providing sodium, potassium and chloride ions. - Electrolyte imbalance: restores normal plasma electrolyte concentrations after losses due to diarrhea or vomiting. - Bowel preparation: macrogol 4 acts as an osmotic laxative to cleanse the colon before diagnostic procedures.

Common Side Effects: - Mild abdominal discomfort: transient stomach cramping. - Nausea: occasional feeling of queasiness. - Diarrhea: loose stools due to osmotic activity. - Flatulence: increased intestinal gas. - Taste alteration: temporary change in mouthfeel.

Serious or Rare Side Effects: - Severe electrolyte disturbance: hypernatremia or hyperkalemia. - Allergic reaction: rash, itching, swelling. - Persistent vomiting: may lead to further fluid loss. - Acute renal impairment: in patients with pre‑existing kidney disease.

Before using Isocolan, consider the following precautions: - Renal function: assess kidney status in patients with chronic kidney disease. - Cardiac conditions: monitor electrolyte levels in patients with heart failure. - Fluid status: avoid in patients with fluid overload or edema. - Pregnancy and lactation: use only if clearly needed and prescribed. - Drug interactions: review concomitant medications that affect electrolyte balance. - Store at ambient temperature: keep below 25°C, in the original container, protected from moisture and direct sunlight.

Isocolan may interact with other agents that influence electrolyte balance. Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalemia. - Sodium‑containing IV fluids: may cause hypernatremia. - ACE inhibitors or ARBs: can exacerbate potassium elevation.

Moderate Interactions (Monitor Closely): - Loop diuretics: may require electrolyte monitoring. - Laxatives other than macrogol: increase risk of dehydration. - Antacids containing sodium: additive sodium load. - Certain antibiotics (e.g., aminoglycosides): monitor renal function and electrolytes.